Trichomegaly of the eyelashes following treatment with cetuximab
Related Experiment Video
Updated: Aug 17, 2026

03:59
Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomised phase III trial of adjuvant treatment intensification with mFOLFIRINOX versus mFOLFOX6 in high-risk stage III colon cancer: Results of the international IROCAS study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.
medRxiv : the preprint server for health sciences·2026
Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study).
ESMO gastrointestinal oncology·2026
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final analysis of the Neotorch study: perioperative toripalimab in combination with chemotherapy for patients with stage Ⅱ/Ⅲ resectable non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sacituzumab tirumotecan versus chemotherapy in previously treated locally recurrent or metastatic triple-negative breast cancer: final overall survival analysis of the Phase III OptiTROP-Breast01.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy and safety of risvutatug rezetecan versus gemcitabine plus docetaxel in relapsed/refractory advanced osteosarcoma: Primary results from the ARTEMIS-011 phase 3 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Targeting MALT1 in B-cell Lymphomas.
Blood cancer discovery·2026
Targeting BIGH3 in selected solid tumors through a pH-Dependent antibody engineering strategy.
Biochemistry and biophysics reports·2026
Correction: Solving the mystery of persistent isolated aspartate aminotransferase elevation: Macro-AST as a decisive diagnostic consideration.
Frontiers in cellular and infection microbiology·2026
